In The News
ASIC seeks $20M penalty against Kraken crypto exchange
Coles, Woolworths hit with class actions over discount claims
Judge balks at idea government could act for Robodebt class action members
Parties race to settle Exactech joint implant class action
ACCC worried Cleanaway’s $110M Citywide tie-up may trash competition
ASIC slams ‘false’ premise of payday lender BSF’s appeal
Uber accused of refusing rides for blind passenger at Melbourne Airport
Telstra did not discriminate by standing down Triple-0 worker with hearing loss: court
Insurer Marsh breached obligation in case over $7B Greensill collapse: court
Novartis loses case against Pharmacor over blood pressure drug
Please login to bookmarkClose

Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India’s Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au